Company logo

ATIP - ATI Physical Therapy, Inc.

NYSE -> Healthcare -> Medical Care Facilities
Bolingbrook, United States
Type: Equity

ATIP price evolution
ATIP
(in millions $) 30 Oct 2023 30 Jul 2023 1 May 2023 31 Jan 2023
Current assets
Cash $19.7 $63.08 $83.14
Short term investments
Net receivables $85 $80.8 $82.21 $80.67
Inventory
Total current assets $123.5 $139 $166.85 $194.13
Long term investments
Property, plant & equipment $317.5 $333.6 $344.23 $349.78
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $978.5 $1010.3 $1045.76 $1078.98
Current liabilities
Accounts payable $11.5 $12.5 $10.24 $12.56
Deferred revenue
Short long term debt
Total current liabilities $119.4 $126.5 $111.22 $116.52
Long term debt $512.8 $512 $534.14 $531.6
Total noncurrent liabilities
Total debt
Total liabilities $945.4 $874.4 $889.79 $894.69
Shareholders' equity
Retained earnings -$1403.7 -$1388.5 -$1365.78 -$1339.51
Other shareholder equity -$89.2 $0.6 $1.44 $4.9
Total shareholder equity
(in millions $) 31 Jan 2023 31 Jan 2022 30 Jan 2021
Current assets
Cash $83.14 $48.62 $1.31
Short term investments
Net receivables $80.67 $82.45 $90.71
Inventory
Total current assets $194.13 $143.58 $1.66
Long term investments
Property, plant & equipment $349.78 $396.38 $395.4
Goodwill & intangible assets
Total noncurrent assets $345.02
Total investments
Total assets $1078.98 $1562.69 $346.68
Current liabilities
Accounts payable $12.56 $15.15 $1.57
Deferred revenue
Short long term debt
Total current liabilities $116.52 $137.33 $1.69
Long term debt $531.6 $543.8 $1154.75
Total noncurrent liabilities $339.99
Total debt
Total liabilities $894.69 $1058.28 $341.68
Shareholders' equity
Retained earnings -$1339.51 -$847.13 -$13.61
Other shareholder equity $4.9 $0.03 -$0
Total shareholder equity
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Revenue
Total revenue $156.79 $163.29
Cost of revenue
Gross Profit $15.07 $23.28
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $28.06 $35.31
Operating income
Income from continuing operations
EBIT
Income tax expense -$7.22 -$13.03
Interest expense -$11.78 -$11.38
Net income
Net income -$116.32 -$135.55
Income (for common shares)
(in millions $) 31 Jan 2022 30 Jan 2021
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1.61
Operating income -$1.61
Income from continuing operations
EBIT
Income tax expense
Interest expense
Net income
Net income -$13.61
Income (for common shares)
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$21.86 -$17.62 -$8.66 -$39.89
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $80.89 $81.42 $81.57 -$11.52
Effect of exchange rate
Change in cash and equivalents -$0.05 $31.06 $46.18 -$93.51
(in millions $) 31 Jan 2022 30 Jan 2021
Net income -$13.61
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$0.56
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$39.89 -$345
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$11.52 $346.87
Effect of exchange rate
Change in cash and equivalents -$93.51 $1.31
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 1.03
Quick ratio N/A